ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,000 | +11.6% | 1,396,555 | +15.1% | 0.01% | +50.0% |
| Q2 2023 | $4,479 | +39.1% | 1,213,735 | +24.7% | 0.01% | +50.0% |
| Q1 2023 | $3,221 | +19.3% | 973,235 | +39.8% | 0.00% | 0.0% |
| Q4 2022 | $2,700 | -99.8% | 695,935 | +9.0% | 0.00% | +100.0% |
| Q3 2022 | $1,551,000 | +8.0% | 638,400 | -12.0% | 0.00% | 0.0% |
| Q2 2022 | $1,436,000 | +49.0% | 725,500 | +37.7% | 0.00% | +100.0% |
| Q1 2022 | $964,000 | +95.9% | 526,700 | +51.0% | 0.00% | 0.0% |
| Q4 2021 | $492,000 | +85.0% | 348,900 | +48.5% | 0.00% | – |
| Q3 2021 | $266,000 | -5.3% | 235,000 | +33.8% | 0.00% | – |
| Q2 2021 | $281,000 | -76.0% | 175,626 | -6.7% | 0.00% | -100.0% |
| Q3 2018 | $1,169,000 | +785.6% | 188,300 | +544.9% | 0.00% | – |
| Q2 2018 | $132,000 | +109.5% | 29,200 | +43.8% | 0.00% | – |
| Q3 2017 | $63,000 | +50.0% | 20,300 | +79.6% | 0.00% | – |
| Q2 2017 | $42,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |